mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.04 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.04 |
mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.04 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.04 |
mRNA |
QL-VIII-58 |
GDSC1000 |
pan-cancer |
AAC |
0.093 |
0.04 |
mRNA |
QL-XII-47 |
GDSC1000 |
pan-cancer |
AAC |
0.066 |
0.04 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.04 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
0.092 |
0.04 |
mRNA |
AZD7762 |
GDSC1000 |
pan-cancer |
AAC |
0.065 |
0.04 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.04 |